Patients with History of Breast Cancer Face Increased Risk of Heart Disease
Study finds elevated risk factors for cardiovascular disease in postmenopausal women with a history of breast cancer.
A new study published in Menopause, a journal through the North American Menopause Society (NAMS), has found that postmenopausal women with breast cancer are at greater risk for developing heart disease.
The study included 96 postmenopausal patients with a history of breast cancer and compared them with 192 postmenopausal women. Groups were matched by age, time since menopause, and body mass index. The purpose of the study was to compare and evaluate risk factors for cardiovascular disease in postmenopausal women with a history of breast cancer to women without a history of breast cancer.
The investigators found that postmenopausal women with a history of breast cancer showed a stronger association with metabolic syndrome, diabetes, atherosclerosis, hypertriglyceridemia, and abdominal obesity, which are major risk factors for cardiovascular disease. They also found that the risk of cardiovascular mortality increased to match mortality rates from cancer.
Cardiovascular disease is the main cause of death in postmenopausal women, and women treated for breast cancer are at a greater risk of developing heart disease than those who do not have a history of the disease. According to the
"Heart disease appears more commonly in women treated for breast cancer because of the toxicities of chemotherapy, radiation therapy, and use of aromatase inhibitors, which lower estrogen. Heart-healthy lifestyle modifications will decrease both the risk of recurrent breast cancer and the risk of developing heart disease," said JoAnn Pinkerton, MD, executive director of NAMS. "Women should schedule a cardiology consultation when breast cancer is diagnosed and continue with ongoing follow-up after cancer treatments are completed."
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025